PHX.AU Pharmx Technologies Ltd

Healthcare Software Australian Securities Exchange
0.0690 AUD
Close of Oct 29, 2026
0.0640 0.1800
Market cap
AUD 46.1M
P/E
-
P/B
1.98x
ROE
-7.8%
Dividend yield
-
Fundamental score
1.6/5

Ratios use the latest price and the fiscal year ending Jun 2026.

Is PHX.AU undervalued?

Graham number

The Graham number of Pharmx Technologies Ltd cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Pharmx Technologies Ltd fundamental analysis

7 of 21 checks passed

ROE 0/2

Low return on equity (-7.8%), below 10%.

ROA 1/1

Return on assets (-6.7%) is above the industry median (-7.3%).

Profit Consistency 0/2

Not profitable for at least 3 consecutive years.

Earnings Growth 5Y 0/1

Earnings per share did not grow over the past 5 years.

Earnings Acceleration 0/1

Not enough positive earnings history to compare last year's growth with the 5-year average.

Earnings Growth vs Industry 0/1

Last year's EPS growth (-567.8%) is below the industry median (19.3%).

Revenue Growth 1/2

Revenue grew 8.2% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 2/2

Low debt to equity (2.3%), 40% or less.

Debt Trend 0/1

Debt to equity has risen over the past 5 years.

Cash Runway 2/2

Loss-making but free cash flow is positive.

PE vs Market 0/1

PE is negative or not available.

PE vs Industry 0/1

PE is negative or not available.

PBV 1/1

Price to book (2.0x) is below the industry median (3.2x).

Graham Number 0/1

Graham number needs positive earnings and book value.

PEG 0/1

PEG needs positive PE and positive 5-year earnings growth.

Dividend Yield 0/2

No dividend paid in the last reported year.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 0/1

Dividends paid did not grow over the past 5 years.

Payout Ratio 0/1

No dividend, or no profit to pay it from.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

Pharmx Technologies Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Pharmx Technologies Ltd

Pharmx Technologies Limited, together with its subsidiaries, engages in the technology and software development business in Australia and New Zealand. It offers Pharmx Gateway, an electronic ordering and invoicing solution; Pharmx Marketplace, an e-commerce ordering platform; and Pharmx Analytics, a solution that provides insights for suppliers and buyers. The company was formerly known as Corum Group Limited and changed its name to Pharmx Technologies Limited in October 202…

Full company profile